Tag: glycan–lectin interactions

Glycomimetic peptides as powerful anti-inflammatory treatments

Written by

Glycan (sugar)-binding lectin-type receptors on immune cells have the potential to serve as therapeutic targets. However, many of these receptors are not targeted because of a lack of suitable binding agents. Professor J Kenneth Hoober and Dr Laura L Eggink, co-founders of Susavion Biosciences, Inc, and Wild Boar Biosciences, LLC, have created peptide mimetics of glycans that show greater flexibility […]

Read More… from Glycomimetic peptides as powerful anti-inflammatory treatments